2007
|
Sign up to set email alerts
Paclitaxel Maculopathy
Search citation statements
Order By: Relevance
Paper Sections
Select...
82
29
10
1
Citation Types
7
75
1
0
Year Published
Range
2008
20082026
2026Publication Types
Select...
95
11
3
1
Relationship
0
110
Authors
Journals
Cited by 110 publications
(83 citation statements)
References 0 publications
7
75
1
0
Order By: Relevance
Smart CitationsHow this paper cites the one you are viewing
“……”
Section: Discussion
supporting
confidence: 89%
Smart CitationsHow this paper cites the one you are viewing
“……”
Section: Discussion
supporting
confidence: 89%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The pathophysiology of CME in this case is unclear, but we propose that CME secondary to paclitaxel use may be not associated with vascular endothelial grow factor or intraocular inflammation considering the lack of effectiveness of bevacizumab plus triamcinolone. As in the case of Joshi and Garretson [5], our study confirmed that macular edema associated with paclitaxel use shows spontaneous resolution and improvement of visual acuity after a change of chemotherapeutic regimen. Ophthalmic evaluation is needed in all patients using paclitaxel or docetaxel.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Following the cessation of paclitaxel and ocular instillation, CME was cured. Our observation confirmed that CME secondary to paclitaxel shows spontaneous resolution of visual complaint and macular edema by removing the causing agent [ 3 ].…”
Section: Discussion
supporting
confidence: 85%
Smart CitationsHow this paper cites the one you are viewing
“……”
Section: Discussion
supporting
confidence: 89%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The pathophysiology of CME in this case is unclear, but we propose that CME secondary to paclitaxel use may be not associated with vascular endothelial grow factor or intraocular inflammation considering the lack of effectiveness of bevacizumab plus triamcinolone. As in the case of Joshi and Garretson [5], our study confirmed that macular edema associated with paclitaxel use shows spontaneous resolution and improvement of visual acuity after a change of chemotherapeutic regimen. Ophthalmic evaluation is needed in all patients using paclitaxel or docetaxel.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Following the cessation of paclitaxel and ocular instillation, CME was cured. Our observation confirmed that CME secondary to paclitaxel shows spontaneous resolution of visual complaint and macular edema by removing the causing agent [ 3 ].…”
Section: Discussion
supporting
confidence: 85%
Smart CitationsHow this paper cites the one you are viewing
“……”
Section: Discussion
supporting
confidence: 89%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The pathophysiology of CME in this case is unclear, but we propose that CME secondary to paclitaxel use may be not associated with vascular endothelial grow factor or intraocular inflammation considering the lack of effectiveness of bevacizumab plus triamcinolone. As in the case of Joshi and Garretson [5], our study confirmed that macular edema associated with paclitaxel use shows spontaneous resolution and improvement of visual acuity after a change of chemotherapeutic regimen. Ophthalmic evaluation is needed in all patients using paclitaxel or docetaxel.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Following the cessation of paclitaxel and ocular instillation, CME was cured. Our observation confirmed that CME secondary to paclitaxel shows spontaneous resolution of visual complaint and macular edema by removing the causing agent [ 3 ].…”
Section: Discussion
supporting
confidence: 85%